VEVYX | WFPCX | VEVYX / WFPCX | |
Total Expense Ratio | 0.66 | 1.87 | 35% |
Annual Report Gross Expense Ratio | 0.66 | 1.87 | 35% |
Fund Existence | 13 years | 18 years | - |
Gain YTD | 3.081 | 6.407 | 48% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.5B | 14B | 125% |
Annual Yield % from dividends | 1.08 | 0.26 | 417% |
Returns for 1 year | -7.43 | -2.92 | 254% |
Returns for 3 years | 3.79 | 6.66 | 57% |
Returns for 5 years | 36.95 | 32.37 | 114% |
Returns for 10 years | 55.23 | 51.12 | 108% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NOVP | 29.41 | 0.07 | +0.23% |
PGIM S&P 500 Buffer 12 ETF - Nov | |||
FTXH | 27.76 | 0.05 | +0.19% |
First Trust Nasdaq Pharmaceuticals ETF | |||
FHLC | 65.55 | 0.08 | +0.12% |
Fidelity MSCI Health Care ETF | |||
GLU | 17.91 | -0.05 | -0.28% |
Gabelli Utility & Income Trust (The) | |||
EELV | 26.35 | -0.15 | -0.57% |
Invesco S&P Emerging Markets Low Vol ETF |